Total Valuation
Dong Wha Pharm Co., Ltd. has a market cap or net worth of ₩132.49B. The enterprise value is ―.
Market Cap₩132.49B
Enterprise Value―
Share Statistics
Dong Wha Pharm Co., Ltd. has 27,931,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,931,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dong Wha Pharm Co., Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is -0.10%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)-0.10%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee609.07M
Profits Per Employee10.66M
Employee Count815
Asset Turnover0.77
Inventory Turnover2.99
Valuation Ratios
The current PE Ratio of Dong Wha Pharm Co., Ltd. is 7.1. Dong Wha Pharm Co., Ltd.’s PEG ratio is 0.36.
PE Ratio7.1
PS Ratio0.35
PB Ratio0.46
Price to Fair Value0.46
Price to FCF-4.66
Price to Operating Cash Flow9.75
PEG Ratio0.36
Income Statement
In the last 12 months, Dong Wha Pharm Co., Ltd. had revenue of 496.39B and earned 8.69B in profits. Earnings per share was 313.37.
Revenue496.39B
Gross Profit203.33B
Operating Income-809.25M
Pretax Income6.00B
Net Income8.69B
EBITDA21.16B
Earnings Per Share (EPS)313.37
Cash Flow
In the last 12 months, operating cash flow was 13.59B and capital expenditures -44.42B, giving a free cash flow of -30.83B billion.
Operating Cash Flow13.59B
Free Cash Flow-30.83B
Free Cash Flow per Share-1.10K
Dividends & Yields
Dong Wha Pharm Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.06
52-Week Price Change-30.90%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)511.62K
Important Dates
Dong Wha Pharm Co., Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateJun 17, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Dong Wha Pharm Co., Ltd. as a current ratio of 1.07, with Debt / Equity ratio of 31.50%
Current Ratio1.07
Quick Ratio0.59
Debt to Market Cap0.59
Net Debt to EBITDA4.97
Interest Coverage Ratio-0.18
Taxes
In the past 12 months, Dong Wha Pharm Co., Ltd. has paid 2.16B in taxes.
Income Tax2.16B
Effective Tax Rate0.36
Enterprise Valuation
Dong Wha Pharm Co., Ltd. EV to EBITDA ratio is 13.22, with an EV/FCF ratio of -7.46.
EV to Sales0.56
EV to EBITDA13.22
EV to Free Cash Flow-7.46
EV to Operating Cash Flow17.82
Balance Sheet
Dong Wha Pharm Co., Ltd. has ₩21.97B in cash and marketable securities with ₩122.24B in debt, giving a net cash position of -₩100.27B billion.
Cash & Marketable Securities₩21.97B
Total Debt₩122.24B
Net Cash-₩100.27B
Net Cash Per Share-₩3.59K
Tangible Book Value Per Share₩11.44K
Margins
Gross margin is 43.01%, with operating margin of -0.16%, and net profit margin of 1.75%.
Gross Margin43.01%
Operating Margin-0.16%
Pretax Margin1.21%
Net Profit Margin1.75%
EBITDA Margin4.26%
EBIT Margin-0.16%
Analyst Forecast
The average price target for Dong Wha Pharm Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.29%
EPS Growth Forecast615.46%